How commonly is COPD misdiagnosed? COPD is frequently underdiagnosed or misdiagnosed, with underdiagnosis rates varying from 10–95% and overdiagnosis rates from 5–60% worldwide.

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, marking the second biologic approved as an add-on maintenance treatment ...

Oct. 2, 2024 — The FDA has approved Regeneron and Sanofi’s drug Dupixent for patients with COPD (chronic obstructive pulmonary disease). Marking the sixth indication for the drug, the approval ...

For some patients with chronic obstructive pulmonary disease (COPD), summer can be one of the most stressful times of the year. Not only is allergy season in full swing, but rising temperatures ...

Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial. Nature Aging, 2024; DOI: 10.1038/s43587-024-00758-1 ...